Protection against methoxyacetic-acid-induced spermatocyte apoptosis with calcium channel blockers in cultured rat seminiferous tubules: possible mechanisms

Toxicology and Applied Pharmacology
L H LiR E Chapin

Abstract

A calcium-mediated mechanism underlying spermatocyte apoptosis induced by 2-methoxyethanol (2-ME) has been previously proposed. This hypothesis was tested in vitro in the present study using cultured juvenile (25 days old) and adult rat seminiferous tubules (JRST and ARST, respectively) with methoxyacetic acid (MAA, the active metabolite of 2-ME). In JRST, spermatocyte degeneration was morphologically obvious 19 hr after a 5-hr exposure to 5 mM MAA. The lesion was unaffected by the presence or absence of extratubular Ca2+. However, MAA-induced cell death was significantly prevented by cotreatment with the dihydropyridines (DHP) nifedipine (50 microM) and nicardipine (20 microM), as well as verapamil (50 microM) and TMB-8 (50 microM), all of which are able to inhibit calcium movement through plasma membranes. However, neither ryanodine, dantrolene, nor cyclosporin A and ruthenium red, which inhibit Ca2+ mobilization from intracellular stores (endoplasmic reticulum and mitochondria), affected the MAA-induced cell death. Inhibition of calcium mobilization through IP3-sensitive pathways by blocking the product of IP3 with manoalide, neomycin, and U73122 did not block the MAA-induced lesion. The protective effects of 50 microM nifed...Continue Reading

References

Jun 1, 1992·Trends in Pharmacological Sciences·W A Catterall, J Striessnig
May 1, 1990·The American Journal of Physiology·T E Gunter, D R Pfeiffer
Mar 1, 1990·Environmental Health Perspectives·J L Farber
Jun 1, 1989·Molecular and Cellular Endocrinology·R W HollD A Leong
Jan 1, 1989·Toxicology and Applied Pharmacology·B F TrumpK A Elliget
Dec 1, 1989·Trends in Pharmacological Sciences·D J Triggle, D Rampe
Jul 1, 1985·The Journal of Surgical Research·M A McMillenR B Wait
Feb 15, 1988·Archives of Biochemistry and Biophysics·E G PopovZ A Gabbasov
Dec 1, 1986·Experimental and Molecular Pathology·D M CreasyW H Butler
May 1, 1985·Analytical Biochemistry·C M DeberS Grinstein
Jul 1, 1985·Toxicology and Applied Pharmacology·E J MossT J Gray
Jul 1, 1985·Toxicology and Applied Pharmacology·T J GrayS D Gangolli
Aug 27, 1985·Biochemistry·J S MillsJ D Johnson
Jun 1, 1983·Toxicology·B D Hardin
Jan 1, 1984·Toxicologic Pathology·R E ChapinJ C Lamb
Apr 1, 1984·Experimental and Molecular Pathology·D M Creasy, P M Foster
Sep 1, 1995·General Pharmacology·M Lucas, V Sánchez-Margalet
Feb 1, 1995·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·B F Trump, I K Berezesky
Oct 1, 1994·Cell Calcium·P NicoteraS Orrenius
Oct 1, 1994·Experimental and Molecular Pathology·W W KuR N Wine
Jun 1, 1994·The American Journal of Physiology·R CoronadoD M Vaughan
Apr 1, 1994·European Journal of Biochemistry·L Andreeva, M Crompton
Jan 1, 1994·Methods in Cell Biology·P A DilibertoB Herman
Jan 1, 1994·Clinical Pharmacology and Therapeutics·P B DePetrilloN S Andrawis

❮ Previous
Next ❯

Citations

Sep 23, 2010·Journal of Assisted Reproduction and Genetics·Jae Ho LeeChurl K Min
Jul 11, 2013·PloS One·Olajumoke Omolara OjoSrikanta Kumar Rath
May 27, 2015·International Journal of Molecular Sciences·Keshab R ParajuliZongbing You
Feb 1, 2005·Life Sciences·Chia-Hsien Lin, Ming-Cheng Tsai
Apr 2, 2011·Reproductive Biology and Endocrinology : RB&E·Gargi BagchiDavid J Waxman
Dec 10, 1999·Journal of the American College of Cardiology·R P Mason
Jun 23, 2010·Reproductive Biology and Endocrinology : RB&E·Gargi BagchiDavid J Waxman
Jun 14, 2000·Critical Reviews in Toxicology·G Johanson
Feb 24, 2001·Toxicologic Pathology·D M Creasy
Jun 17, 2005·Birth Defects Research. Part A, Clinical and Molecular Teratology·Aceng RuyaniJun Ho Chung
Dec 6, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Fortunata BaroneAngela D'Agostino
Jul 29, 1998·Oral Diseases·R I Marshall, P M Bartold
Dec 28, 2002·The Journal of Biological Chemistry·Yu-Ying HeColin F Chignell
May 1, 2014·Spermatogenesis·Caitlin J Murphy, John H Richburg
Feb 17, 2000·European Journal of Pharmacology·S W Rabkin, J Y Kong
Nov 21, 2000·Free Radical Biology & Medicine·A V Rao, C Shaha
Aug 1, 1999·Toxicology in Vitro : an International Journal Published in Association with BIBRA·C PineauB Jégou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis